Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) is -50.62% lower on its value in year-to-date trading and has touched a low of $1.84 and a high of $74.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BDRX stock was last observed hovering at around $2.34 in the last trading session, with the day’s loss setting it -0.34%.
Currently trading at $2.00, the stock is -27.66% and -46.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing -14.53% at the moment leaves the stock -79.72% off its SMA200. BDRX registered -92.98% loss for a year compared to 6-month loss of -79.00%. The firm has a 50-day simple moving average (SMA 50) of $3.72704 and a 200-day simple moving average (SMA200) of $9.862815.
The stock witnessed a -53.49% gain in the last 1 month and extending the period to 3 months gives it a -51.81%, and is 0.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.10% over the week and 16.33% over the month.
Biodexa Pharmaceuticals Plc ADR (BDRX) has around 21 employees, a market worth around $1.16M and $0.10M in sales. Profit margin for the company is -8253.12%. Distance from 52-week low is 8.71% and -97.30% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.99%).
The EPS is expected to grow by 99.87% this year, but quarterly earnings will post -100.00% year-over-year.
10.0 institutions hold shares in Biodexa Pharmaceuticals Plc ADR (BDRX), with institutional investors hold 32.75% of the company’s shares. Institutions hold 29.86% of the Float.
